Mr James Leggate is a Consultant Neurosurgeon based at Salford Royal NHS Foundation Trust.

Mr Leggate trained in oncology in London, Edinburgh and Marseille. His practice has encompassed Paediatric as well as Adult oncology He now concentrates on Adult Cranial and Spinal oncology. He is the Senior Oncology Neurosurgeon in the Greater Manchester Neurosciences Centre. He is the Lead Neurosurgeon for Stereotactic Radiosurgery having established the service in Manchester in 2012.

Mr Hassan Malik is a Consultant Hepatobiliary Surgeon and Clinical lead for digestive surgery at University Hospital Aintree.

Mr Malik has introduced complex liver surgical techniques within the unit. These include vascular resections and the use of transplant techniques to facilitate liver resections. 

He has extensive experience having performed in excess of 450 liver resections. In addition he has an interest in retroperitoneal sarcoma surgery.

Mr Malik has also led development of an active research programme that has links to The University of Liverpool, The Liverpool CRUK Trials Unit, MRC centre for drug safety, Royal Liverpool University hospital, Clatterbridge and The Christie Oncology Hospitals. He is currently supervising a number of PhD and MD students and has in excess of 60 publications within his field of interest.

Mr Malik is also a member of the NCRN Hepatobiliary and Upper Gastrointestinal subgroup as well as honorary secretary to the British Association of Surgical Oncology. In addition he is an active participant in a number of professional associations .

Dr Hamid Sheikh is a Consultant Clinical Oncologist at The Christie NHS Foundation Trust in Manchester.

Dr Sheikh took his position at Christie Hospital Foundation Trust in 2009 and is the Clinical Oncology Lead for upper GI cancer. Also at The Christie he is involved in UK research trials.

Dr Sheikh covers Lung Cancer services for the populations of Salford and East Cheshire and surrounding areas and offers intra-luminal brachytherapy service for treating tumours in airways.

Dr Sheikh speaks multiple lanuages including English, Urdu, Hindi.

Professor Gordon Jayson is a Consultant Medical Oncologist based at The Christie NHS Foundation Trust in Manchester.

Professor Jayson has developed new treatments for cancer, in particular ovarian cancer, focusing principally on drugs that block blood vessel formation to starve tumours of oxygen and nutrients. Professor Jayson provides a supra-regional service for patients with new diagnoses and previously treated ovarian cancer.

Having trained in medicine at Oxford University, Professor Jayson trained in oncology and undertook a PhD in molecular biochemistry and angiogenesis in Manchester and the Christie Hospital.

Following his PhD, Professor Jayson has conducted post-doctoral research that aims to translate the new data from heparan sulfate biology into the clinic. His current programme of work is directed at the laboratory development of novel oligosaccharides as anti-angiogenic agents and the early and late clinical trial evaluation of this class of drugs. The latter programme aims to identify serological and imaging based biomarkers that will identify the patients who are most likely to benefit from this these agents and which will be used to underpin the development of combination regimens of biological agents. This work is largely focused on ovarian cancer, the disease that Professor Jayson looks after in Christie Hospital.

Professor Gareth Evans is a Professor of Medical Genetics and Cancer Epidemiology based at The Central Manchester NHS Foundation Trust and Manchester University.

Prof Evans trained at St Mary's Hospital Medical School, London between 1978-83 and he held a RAMC Cadetship in 1980. 

Professor Evans has established a national and international reputation in clinical and research aspects of cancer genetics, particularly in neurofibromatosis and breast cancer. He has developed a clinical service for cancer genetics in the North West Region of England, which is nationally regarded. He is an important opinion leader nationally through membership of committees and was chairman of the NICE Familial Breast Cancer Guideline Development Group (2002-2010) and is now clinical lead (2011-current day). He lectures throughout the UK and internationally including, two invited lecture tours across Australia in 1995 and 2001, on hereditary breast cancer and cancer syndromes and has developed a national training program for clinicians, nurses and genetic counsellors in breast cancer genetics, establishing a system for risk assessment and counselling for breast cancer.

Professor Evans is a member of the Europoean Society of Human Genetics and is also an Ex Council Member of the Clinical Genetics Society, Member and Ex Chairman of the Cancer Genetics Group, Member and ex Council Member of the British Society of Genomic Medicine. 

Professor Evans Speaks English, Welsh and French.

Mr Finlay Curran is a Consultant General and Colorectal Surgeon based at Manchester Royal Infirmary.

Mr Curran provides high quality care. He qualified from the University of Glasgow in 1989 and then trained in Merseyside, Glasgow and Manchester. He also sent time in Tubingen, Germany on a Royal College Travelling Fellowship. He was appointed as a Consultant Surgeon in 2001, initially working in Stockport, then moving to Manchester Royal Infirmary in 2010.

Mr Curran specialises in endoscopy and hernia, colorectal and pelvic floor surgery. He performs both laparoscopic and open surgery.

Mr Curran has been involved in research throughout his career. He was the UK lead for an international multi-centred trial and has participated in other national trials within surgery. He has published in scientific journals and presented award winning research nationally and internationally. He is a member of the Association of Coloproctology of Great Britain & Ireland, an examiner for the University of Manchester and a Royal College of Surgeons Tutor.

Dr Ed Smith is a Consultant Clinical Oncologist based at The Christie NHS Foundation Trust in Manchester.

Dr Smith trained at the University of Oxford, gaining his medical degree as well as a degree in Physiological Sciences. As a junior he worked in Oxford, Newcastle, and London Teaching Hospitals.

Dr Smith started at The Christie in 2000, and later becoming a Consultant after completion of his specialist training in Clinical Oncology in 2007.

His practice is primarily related to Lymphoma and other haematological disorders (giving chemotherapy and radiotherapy). 

Dr Smith has interests in treating young people with Lymphoma, and these patients are referred  from across the region, to be treated on The Young Oncology Unit at The Christie.  He also practices Paediatric radiotherapy and has a particular interest in using advanced radiotherapy to reduce the risk of late effects of treatment, as well as an in interest in particle therapies (including Proton Therapy).
Dr Smith in involved in and runs a Young Persons Survivorship Course at The Christie and is developing treatment summaries and care plans for patients' use.

Mr David Mowatt is a Consultant Plastic Surgeon at The Christie NHS Foundation Trust in Manchester.

Mr Mowatt qualified in medicine and dentistry from St George’s Hospital, London and Edinburgh University. His special interests are skin cancer (malignant melanoma, squamous cell carcinoma and basal cell carcinoma); sarcoma surgery; surgery of neurofibromatosis; reconstruction following cancer surgery of the face, head and neck; breast reconstruction and gynaecological reconstruction.

Mr Mowatt regularly publishes in the plastic surgery literature and has presented his work nationally and internationally at plastic surgery and scientific meetings. He takes a keen interest and is actively involved in the postgraduate training of future plastic surgeons and feels strongly that the apprenticeship model of training for surgeons is maintained.

Mr David Donnelly is a Consultant Colorectal Surgeon based at Manchester Royal Infirmary.

Mr Donnelly trained in Medicine at The University of Manchester. After graduation with Honours he undertook training in General Surgery throughout the North West before undertaking extensive specialist training in Colorectal Surgery.  

After completion of his training he was sucessfully appointed to the only Surgical Fellowship in the UK to provide experience in advanced lower GI endoscopy. During this time he underwent training in all aspects of colonoscopy for the diagnosis and treatment of polyps. 

Dr David Bottomley is a Consultant Clinical Oncologist based at St James's Hospital in Leeds.

Dr Bottomley qualified in medicine at Westminster Hospital medical school in 1985. Dr Bottomley’s main interests are in prostate cancer. Since 1996 he and his team have been performing seed prostate brachytherapy and Leeds is the longest-established prostate brachytherapy centre in the UK. The team there has recently presented ten-year outcomes for patients undergoing this treatment. They are also highly experienced in performing High Dose Rate (HDR)( temporary) prostate brachytherapy using transrectal ultrasound guidance. Dr Bottomley and the team at Leeds serve as a teaching resource for both seed and HDR prostate brachytherapy and continue to run training courses on the subject.